The operations mentioned in the fourth paragraph of Article L. 1121-13 may only be carried out in the places governed by this section when the research envisaged does not allow these operations to be carried out in a pharmaceutical establishment authorised under Article L. 5124-1.
The corresponding categories of research are defined by order of the Minister for Health issued on a proposal from the Director General of the Agence nationale de sécurité du médicament et des produits de santé.
These operations may only be carried out on batches of medicinal products manufactured or imported under the conditions set out in articles R. 5124-49 to R. 5124-57-6.